Vident Investment Advisory’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22,246
| Closed | -$168K | – | 948 |
|
|
2023
Q2 | $168K | Buy |
22,246
+295
| +1% | +$2.22K | 0.01% | 1086 |
|
|
2023
Q1 | $194K | Buy |
21,951
+2,655
| +14% | +$23.5K | 0.01% | 1111 |
|
|
2022
Q4 | $176K | Buy |
19,296
+7,270
| +60% | +$66.3K | 0.01% | 1053 |
|
|
2022
Q3 | $0 | Buy |
+12,026
| New | – | ﹤0.01% | 1315 |
|
|
2016
Q2 | – | Sell |
-12,734
| Closed | -$682 | – | 392 |
|
|
2016
Q1 | $682 | Buy |
12,734
+9,121
| +252% | +$488 | 0.04% | 363 |
|
|
2015
Q4 | $237K | Buy |
+3,613
| New | +$237K | 0.03% | 357 |
|